RankAlpha logo
Back to Rankings

HBIO

Harvard BioscienceD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
HBIO vs peer average
49/100
HBIO vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

A is the first available peer comparator.

Agilent is a broad life-science-tools operating benchmark, but its much larger scale and diversified mix make it unsuitable as a direct HBIO valuation peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAAgilent
HBIO
Harvard Bioscience
A
Agilent
Grade
D
A
Momentum
94
68
Value
54
61
Sentiment
45
85
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs A

HBIO / A
Grade Position
In line
HBIO vs. peer average (D vs. D)
49/100
Momentum
94
HBIO
Value
54
A
Sentiment
45
A

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HBIO
1
A
A
A
100/100
-3
2
RVTY
RVTY
C
60/100
-1
3
TMO
TMO
B
80/100
-2
4
GNTA
Genenta Science SpA ADR
F
20/100
+1
5
BCTX
BriaCell Therapeutics Corp Common
F
20/100
+1
A is the first peer returned for this comparison set.